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Abstract: The aim of this study was to evaluate the occurrence of Cryptosporidium oocysts in a 
drinking water treatment plant (DWTP) located in a rural area of northern Italy. Influent and 
effluent samples were collected at the DWTP over three years (2013–2016). In parallel, tap water 
samples from a public drinking fountain were collected as well. All samples were analyzed for the 
presence of Cryptosporidium spp. oocysts by a common method based on an immunomagnetic 
separation (IMS)/immunofluorescence assay (IFA), complemented by 4,6-diamidino-2-phenylindole 
(DAPI) staining. A reverse transcriptase-PCR (RT-PCR) protocol was added to evaluate oocyst 
viability. The results highlighted a high variability of oocyst concentrations across all samples (mean 
4.3 ± 5.8/100 L) and a high variability in the percentage of DAPI-positive specimens (mean 48.2% ± 
40.3%). Conversely, RT-PCR did not reveal the presence of viable C. parvum and C. hominis oocysts. 
A nested PCR targeting Cryptosporidium 18S ribosomal DNA, carried out in two water samples, 
confirmed the presence of a Cryptosporidium genotype associated with wild animals in the river and 
in tap water. The results obtained underline the vulnerability of the investigated surface water to 
Cryptosporidium spp. contamination. Although the recovered Cryptosporidium genotype is not a 
human pathogen, its presence demonstrates the existence of a potential pathogen Cryptosporidium 
spp. contamination risk. Moreover, these results underline the importance of also considering 
unconventional (not bacterial) biological contaminations (protozoa) in water resources in rural 
areas, including those of developed countries.  
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1. Introduction 
Despite the best available technologies applied in drinking water production and the control 
and surveillance systems put in place, waterborne diseases are still a public health problem even in 
industrialized countries.  
In the United States, 928 waterborne outbreaks were reported from 1971 to 2014. Over forty 
years, various aetiological agents have caused repeated contaminations. Bacteria, viruses, and 
unidentified agents have caused most of these epidemics, but outbreaks by parasites such as 
Cryptosporidium spp. and Giardia intestinalis have also consistently occurred throughout this period 
[1]. 
A similar situation has also occurred in Europe, where in 2017, seven member states of the 
European Union reported 27 waterborne outbreaks caused by different microorganisms, including 
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calicivirus (norovirus), Campylobacter, Cryptosporidium, hepatitis virus, ‘Viruses other than hepatitis 
A virus and Calicivirus, Shiga toxin-producing E. coli, parasites (other than Cryptosporidium and 
Trichinella) and unknown agents [2]. Between January 2011 and December 2016, 381 waterborne 
outbreaks due to parasitic protozoa (e.g., Giardia spp., Cryptosporidium spp.) were reported 
worldwide. Forty-nine percent of the events occurred in New Zealand, 41% in North America and 
9% in Europe [3]. 
Cryptosporidium spp. display a global distribution, and a number of species are recognized as 
human pathogens, although most cases are due to C. hominis and C. parvum. These microorganisms 
were considered responsible for most of the waterborne outbreaks associated with Cryptosporidium 
typed to date, except for a few other species as confirmed by the outbreak in the UK caused by C. 
cuniculus [4]. Pathogenic Cryptosporidium gives rise to self-limiting gastrointestinal diseases that are 
difficult to cure with current drugs and potentially lethal in immunocompromised subjects [5,6]. 
The first documented epidemic due to the consumption of water contaminated by 
Cryptosporidium spp. was reported in the United States in 1985, and the largest outbreak caused by 
Cryptosporidium spp. occurred in the city of Milwaukee in 1993. Based on epidemiological studies 
conducted in that area, it was possible to verify that the number of subjects who had manifested the 
symptoms of gastroenteritis between March and April 1993 amounted to approximately 403,000 
people. Four thousand and four hundred individuals were admitted to various hospital facilities, and 
at least 69, most of whom were immunocompromised, eventually died. The origin of this event was 
attributed to the inefficiency of one of the two drinking water treatment plants catching water from 
nearby Lake Michigan. In the period immediately preceding the outbreak, strong spring 
thunderstorms had increased the lake turbidity, causing an increase in the passage of particulates 
and reasonably also of oocysts of Cryptosporidium spp. throughout the plant [7]. 
Over the past decade, several outbreaks of cryptosporidiosis have been reported in many EU 
countries in association with the consumption of contaminated drinking water, recreational waters 
(especially swimming pools), food consumption and contact with animals [8–10]. 
In the United Kingdom, cases occurred more frequently in spring, mostly due to C. parvum, and 
were presumably generated by increased exposure to oocysts from young animals, in conjunction 
with the season of births [11]. In recent years, the phenomenon has lessened due to greater veterinary 
checks and, above all, to the quality improvement of water for human consumption [12]. At the same 
time, however, there has been an increase in contamination during the summer–autumn period 
caused mainly by C. hominis; this increased contamination is probably linked to an increase in 
exposure of the subjects to contaminated recreational water [13]. 
In 2010–2011, the two largest epidemics ever reported in Europe were recorded in Sweden. 
Approximately 47,000 people from two different cities (Östersund and Skellefteå) were involved. C. 
hominis caused both outbreaks, and the consumption of water from a contaminated supply source 
was identified as the cause of these two outbreaks [14,15]. 
In August 2013, in the German city of Halle, 167 people, mostly children, showed the classic 
symptoms of cryptosporidiosis. The outbreak was caused by the consumption of water contaminated 
by wastewater following the flooding of the Saale River. Analysis of environmental samples showed 
a high number of oocysts (up to 592 oocysts/100 L) of C. hominis [10]. 
In Italy, the only documented outbreak linked to the consumption of water contaminated by 
Cryptosporidium spp. occurred in 1995 in the Emilia Romagna Region, in a drug rehabilitation 
community (1,731 people). Two hundred ninety-four people manifested acute diarrhea, with a higher 
attack rate in HIV-positive subjects than in HIV-negative subjects [16]. 
To reduce the risk of cryptosporidiosis due to drinking water, the intervention keys are 
catchment protection, appropriate treatment (especially the installation of a filtration step), and 
secondary disinfection, such as by ultraviolet light [17]. In Italy, especially in mountain areas, small 
drinking water plants that often distribute surface water after filtration and chlorination treatments 
or UV treatment serve many small villages. Moreover, in these areas, breeding activities and wild 
animals are often present; therefore, surface waters are potentially at risk of contamination by 
Cryptosporidium spp. In this context, the real infection risk should consider the oocysts’ viability. 
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Among inactivation treatments, UV has been shown to heavily damage DNA, and even if membranes 
and enzymes seem to remain intact, the organism is no longer capable of replicating [18].  
Both in vitro and in vivo methods have been developed to evaluate the viability and infectivity 
of oocysts. In vitro methods include parasite excystation, and fluorogenic dye inclusion/exclusion 
(4,6-diamidino-2-phenylindole, DAPI), coupled or not with DNA amplification. Moreover, the ability 
of Cryptosporidium to invade cells and replicate within them, such as the presence of specific mRNA 
monitored with reverse transcriptase-polymerase chain reaction (RT-PCR), could be used to evaluate 
the oocysts’ viability. In vivo methods consist of animal infectivity assays [19]. 
The aim of this study was to evaluate Cryptosporidium contamination using common microscopic 
and molecular methods in a drinking water plant located in a rural area of Italy in order to monitor 
the effectiveness of the UV treatment installed upstream and thereby reduce the risk for the 
population.  
2. Materials and Methods  
2.1. Sampling 
The sampling was carried out in two small towns located approximately 600 m above sea level 
in a pre-mountainous area in northwest Italy. This area is rich in forests and wildlife. The drinking 
water is derived from a surface water resource (stream). 
The environmental sampling was carried out for a period of three years, between May 2013 and 
May 2016, and three different points were monitored: the drinking water source (river, n = 6, IN), the 
effluent of the drinking water treatment plant (n = 9, OUT), and tap water (n = 9) from a public 
drinking fountain located in a district of the municipality selected as a collection point along the 
network. The water samples were filtered through Envirochek HV capsules (Pall Corporation, VWR 
International Srl, Milan, Italy) with a flow rate of 2 L/min. The number of liters sampled varied from 
155 to 1500, related to the water characteristics. The capsules were refrigerated at 4 °C until sample 
processing. All samples were processed within 24 hours of sampling. 
2.2. Drinking Water Treatment Plant 
The municipality is equipped with a drinking water treatment plant (DWTP, with a productivity 
ranging from 14 to 35 m3/h) which consists of the following phases: water catchment from the stream, 
peroxidation with sodium hypochlorite (approximately 1.5 mg/L), filtration on sand, filtration on 
Granular Activated Carbon (GAC), final chlorination (0.15–0.20 mg/L of residual chlorine) and UV 
disinfection (minimum applied dose 400 J/m2), performed with a Wallace and Tiernan Barrier® M900 
UV system equipped with medium pressure lamps, designed for the treatment of 10–1150 m3/h of 
water flow. 
2.3. Cryptosporidium Detection by IFA/DAPI 
The presence of Cryptosporidium oocysts was assessed according to the Italian Official Methods 
for water samples [20]. Briefly, oocysts were eluted by twice washing the capsules with 125 mL of 
eluting solution on a laboratory shaker at 600 osc/min for 5 min. Then, the eluted samples were 
concentrated to a 10 mL volume by centrifugation at 3500 rpm for 10 min and submitted to 
Immunomagnetic Separation (IMS), as recommended by the manufacturers (Dynabeads GC-Combo, 
Invitrogen Dynal, A. S., Oslo, Norway). At this step, an aliquot of a sample was spiked with ≈1000 
viable oocysts (1–6 months of age) suspended in PBS and supplemented with antibiotics provided by 
Waterborne, Inc. (New Orleans, LA, USA) to evaluate recovery of the IMS (positive control). Of the 
110 µL obtained by IMS, 55 µL were used for an immunofluorescence test using the fluorescently 
labelled monoclonal antibody Cryptosporidium Cell Test IF (Cellabs, Sidney, Australia). Slides were 
examined using an epifluorescence microscope. Oocysts showing typical, confirmatory features 
(ovoid or spherical shape, size 4–6 µm, brilliant apple-green fluorescence) were enumerated, and the 
numbers referred to the concentrations of parasite oocysts per 100 L of water (reference volume for 
Int. J. Environ. Res. Public Health 2019, 16, 2055 4 of 10 
 
parasitic protozoa according to Italian law). The mean recovery of the elution and concentration 
phases is 30% (± 5%), as reported in the Italian Official Method [20]. The mean recovery of the IMS 
phase was 99% (± 3%), and it was evaluated with the following formula: 
Recovery% = 100 × [(Nsp – Nusp)/T] 
Nsp = number of oocysts counted in the spiked sample 
Nusp = number of oocysts counted in the unspiked sample 
T = true value of the oocysts or cysts spiked 
The oocyst concentration was calculated with the formula reported below: 
N oocysts/100 L = [(Nm × 2)/Ls] × 100 
Nm = number of oocysts determined by microscopy 
Ls = number of liters sampled 
The presence of nuclei in the oocysts (indicator of oocyst viability) was confirmed by staining 
with the nuclear fluorochrome 4’,6-diamidino-2-phenylindole (DAPI) (Sigma-Aldrich Srl, Milan 
Italy). The percentage of viability was calculated with the formula reported below: 
Viability % = (Nn × 100)/No 
Nn = number of oocysts with DAPI-positive nuclei 
No = number of IFA-positive oocysts 
2.4. Cryptosporidium Detection by Reverse Transcriptase-PCR (RT-PCR) 
The remaining 55 µL of IMS-purified oocysts was used for RT-PCR. Briefly, the suspension was 
centrifuged; the pellet was resuspended in InstaGene Matrix (Bio-Rad, Segrate, Milano, Italy) and 
incubated at 45 °C for 20 min to maximize heat shock protein 70 (hps70) mRNA production. After 
heat shock, lysis-binding buffer (200 µL) provided in the kit (Dynabeads mRNA DIRECT kit, Thermo 
Fisher Scientific, Milan Italy) was added to each sample, and this mixture was then subjected to 
freeze-thaw treatment (five cycles in liquid nitrogen for 30 s and thawing at 37 °C) to disrupt oocysts 
and release nucleic acids. The debris was pelleted and the supernatant containing the mRNA was 
added to oligo(dT)25 magnetic beads. Extraction and isolation of mRNA were carried out according 
to the manufacturer’s instructions. RT-PCR was performed with the GeneAmp Gold RNA PCR Kit 
(Applied Biosystems, Thermo Fisher Scientific, Milan, Italy). Details about the RT-PCR protocol for 
the detection of the C. parvum and C. hominis hsp 70 gene were previously developed [21]. The 
presence of the specific band corresponding to C. parvum and C. hominis (590 pb) was assessed by 
comparison with the amplicon obtained from spiked samples (positive control). A t-test was used to 
compare the mean oocyst concentration and was performed by the statistical package SPSS 25.0 (SPSS 
for Windows, Chicago, IL, USA).  
2.5. Cryptosporidium spp. PCR  
For species identification, DNA was extracted from IMS-captured oocysts by using the 
FastPrep120 apparatus and the FastDNA kit (MP Biomedicals, Santa Ana, USA). A nested PCR assay 
was used to amplify a ~590 bp fragment of the small subunit rRNA (SSU rRNA) gene, as previously 
described [22]. PCR conditions, for both primary and secondary amplification, were as follows: after 
an initial denaturation step at 94 °C for 3 min, 40 cycles of denaturation at 94 °C for 30 sec, annealing 
at 50 °C for 1 min and extension at 72 °C for 1 min were performed, followed by a final extension step 
at 72 °C for 7 min. Negative (no template) and positive (DNA from the C. parvum Moredun strain) 
controls were included in each experiment. PCR was performed using 25 µL of 2X GoTaqGreen 
(Promega, Madison, USA), 10 pmol of each primer, 5.0 µL of DNA, and nuclease-free water up to a 
final volume of 50 µL. Reactions were performed on a Perkin Elmer 9700 apparatus (Life 
Technologies, Carlsbad, USA). Aliquots of PCR products (10 µL) were loaded on a 1.5% agarose gel 
stained with ethidium bromide. PCR products were purified using spin columns (QiaQuick PCR 
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purification kit, Qiagen, Milan, Italy), and sequenced on both strands. Sequences were edited and 
assembled using the software package SeqMan 7.1 (DNASTAR, Madison, USA). BLASTn searches 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) against the GenBank database were used to identify 
Cryptosporidium at the species level. 
3. Results and Discussion 
The concentrations of Cryptosporidium spp. in the different water samples analyzed are reported 
in Table 1.  
Table 1. Details of sampling; concentrations and viability of Cryptosporidium spp. in the different 
water samples analyzed. 
Date Sampling Point Liters Filtered FITC oocysts/100 La DAPI oocysts/100 Lb Viability %c 
May, 2013 OUT DWTP 352 ND ND NC 
Tap Water 568 ND ND NC 
June, 2013 OUT DWTP 480 ND ND NC 
Tap Water 742 ND ND NC 
August, 2013 IN DWTP 303 1.98 ND NC 
OUT DWTP 294 0.68 ND NC 
Tap Water 372 20.43 19.89 97.36 
October, 2013 IN DWTP 252 12.7 3.17 24.96 
OUT DWTP 375 13.87 11.74 84.64 
Tap Water  402 1.49 0.50 33.39 
December, 2013 OUT DWTP 300 2.00 0.67 33.50 
Tap Water 375 1.07 ND NC 
March, 2014 IN DWTP 268 4.48 2.24 50.00 
OUT DWTP 391 1.53 0.51 33.33 
Tap Water 455 1.76 0.88 50.00 
April, 2014 IN DWTP 296 2.03 0.68 33.50 
OUT DWTP 324 2.47 1.23 49.80 
Tap Water 584 1.37 1.37 100.00 
July, 2015 IN DWTP 413 1.45 1.45 100.00 
OUT DWTP 382 0.26 0.26 100.00 
Tap Water 1,500 0.33 0.33 100.00 
May, 2016 IN DWTP 155 11.29 11.29 100.00 
OUT DWTP 610 7.21 6.23 86.41 
Tap Water 810 15.06 12.10 80.34 
ND: not detected; NC: not calculated; a oocysts stained with fluorescently labelled monoclonal 
antibody for Cryptosporidium spp. (FITC); b oocysts that presented nuclei stained with DAPI;  
c percentage of viable oocysts in the sample calculated using DAPI staining. 
Oocysts were found in most samples (83.3%), at both the influent (IN, 100% positive) and 
effluent (OUT, 77.8% positive) of the DWTP, as well as at the designated collection point along the 
network (tap water, 77.8% positive), with the exception of samples collected in May and June 2013. 
In the sampling carried out in August 2013, the influent and effluent of the DWTP were characterized 
by a low contamination level. Conversely, a relatively higher contamination of tap water was 
observed. Although samples were collected simultaneously and thus a real relation between the 
influent, effluent and tap water was not possible, we can speculate that the high contamination in the 
tap water sample could be related to an instantaneous peak of oocysts in the raw water, only partially 
or not at all removed by the potabilization treatment.  
The results obtained highlighted a high variability of oocyst concentrations in all samples 
analyzed (mean 4.4 ± 5.8 /100 L). As reported in Table 1, few peaks of contamination occurred in the 
months of August and October 2013, and in May 2016, in both raw and treated waters, and this could 
be attributed, at least in part, to the increased water flow due to snow melting or increased rainfall, 
which normally occur during these periods. 
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The mean values and the standard deviations of the oocyst concentrations calculated in the 3 
sampling points are shown in Figure 1. The mean values of the effluent were slightly lower than the 
influent values, indicating that the DWTP partially retained the oocysts, even though the difference 
was not statistically significant (t-test).  
 
Figure 1. Mean and standard deviation (SD) of the concentration of Cryptosporidium spp. and number 
of oocysts viable at the different sampling points. The percentage of viable oocysts in the sample was 
calculated using DAPI staining. 
A high variability was also observed in the percentage of samples showing the presence of intact 
nuclei as determined by DAPI staining (all samples mean, 68.1% ± 29.9%). In the samples analyzed 
at the effluent of the DWTP, the percentage of viable oocysts was similar to that of the influent (Figure 
1), suggesting that the high-power UV treatment, inserted in this system to inactivate the oocysts, did 
not seem to produce the desired results. The UV treatment was installed in this DWTP to reduce the 
risk of microbial contamination of the drinking water distributed to the population, because the 
surface water source was derived from a mountain creek. This water source is characterized by a 
variable flow rate depending on the season and the amount of rainfall. Therefore, the concentration 
of microorganisms entering the DWTP can vary greatly. 
It is important to highlight that exposure to UV could cause irreversible damage to 
Cryptosporidium oocysts’ DNA, causing their inactivation [18], although some studies have shown an 
influence of water turbidity on the oocyst inactivation [23]. 
The process of UV inactivation and damage is not immediately observable, so it can be expected 
to find apparently viable oocysts in the samples; moreover, DNA is quite resistant and may be present 
in non-viable or irreparably damaged cells. In these cases, the DAPI dye penetrates into the cell, 
linking to the genetic material and giving rise to false positives [24,25].  
Considering the limitations of DAPI staining and the importance that the viability of pathogens 
has in public health concern, an evaluation of oocyst viability was carried out by RT-PCR. 
Interestingly, none of the samples analyzed was positive according to RT-PCR.  
The microscopic analysis method employed does not allow the identification of Cryptosporidium 
at the species level, since during immunomagnetic separation (IMS), common antibodies for all 
Cryptosporidium species are used to link microspheres and oocysts, and the direct 
immunofluorescence approach was based on an antigen binding an antibody common to the whole 
genus. 
Int. J. Environ. Res. Public Health 2019, 16, 2055 7 of 10 
 
In contrast, RT-PCR was performed to specifically assess the viability of C. parvum and C. 
hominis. To clarify the results obtained, a nested PCR targeting the 18S ribosomal DNA gene was 
performed to identify Cryptosporidium species on samples collected in July 2015 (IN DWTP and Tap 
Water). The PCR products obtained were sequenced and compared with public databases (BLAST 
search system). The nucleotide sequences determined in this study were deposited in the GenBank 
database under the accession numbers MK402221 and MK402222. The results confirmed the presence 
of Cryptosporidium spp. in both samples. The comparison indicated that the sequence found in the IN 
of the DWTP sample was very closely related to a genotype found in bank voles (99% with GenBank 
accession numbers KY644594 and KY644595). The sequence found in the tap water sample showed a 
high similarity (97%) with a sequence found in a drinking water sample in Scotland (GenBank 
accession number HM015878). These data, coupled with the negative results obtained using the RT-
PCR method developed to evaluate the viability of the common human pathogens C. parvum and C. 
hominis, suggest that the waters examined were contaminated by feces from wild rodents.  
The method used during this study (including the RT-PCR protocol) is the Italian Official 
Method that arose from the EPA (Environmental Protection Agency) method 1623 [26]. This is the 
most widely used method worldwide, but it is still expensive and complex. Moreover, it requires 
much experience, especially in microscopic determination. For this reason, the search for 
Cryptosporidium oocysts is not an analysis that is routinely performed by the Italian laboratory of the 
DWTPs, but only if the drinking water comes from surface waters that can present problems of 
contamination by these protozoa.  
The vulnerability of surface water with respect to Cryptosporidium contamination is confirmed 
in the literature. It also emerges that C. parvum and C. hominis remain the species that are mostly 
found both in surface waters and in treated waters worldwide.  
In a recent study conducted in Minnesota, it was found that 40% of the 145 wells examined were 
contaminated with Cryptosporidium spp.; furthermore, out of 45 samples sequenced, 41 were positive 
for C. parvum, 2 were positive for C. hominis, and 2 were positive for C. andersoni [27]. Following the 
examination of the 178 outbreaks that occurred in England and Wales between 2009 and 2017, it was 
highlighted that the transmission of the protozoan occurred mainly via recreational water, animal 
contact, environmental contact, person-to-person spread, drinking water and food. Furthermore, C. 
parvum was identified in 69 outbreaks and C. hominis in 60 cases, while in two cases, both species 
were identified. In one of the two episodes caused by drinking water, C. hominis IbA10G2, C. parvum 
and C. andersoni were identified in the source water, and C. hominis in treated water. C. hominis 
IbA10G2 and IdA18 were identified in the cases [28]. During a study conducted in Colombia, the 
authors investigated the presence of Cryptosporidium spp. in both raw and treated water samples used 
for the production of drinking water. Cryptosporidium spp. were only detected in raw waters both in 
urban areas and in rural areas. In the Cryptosporidium-positive samples, the authors identified C. 
parvum (Subtype IIcA5G3c), C. galli, C. molnari, Cryptosporidium sp. genotype II of bats and 
Cryptosporidium sp. genotype VIII of birds [29]. The spreading of the Cryptosporidium genotype 
associated with wild animals was also confirmed in our results. Only in Colombia were species found 
mainly circulating in animals, even if they were different from those species found in the samples of 
this study. It is also important to remember that in June 2008 in England, an outbreak was caused by 
Cryptosporidium spp., which resulted in 422 cases, of which 32 cases were ascertained with clinical 
analyses. The concentration of oocysts ranged from 0.0005 to 0.08 oocysts/L in drinking water. 
Molecular analyses have shown that C. cuniculus, a typical species of rats, is also capable of infecting 
humans. The problem was caused by a fresh wild rabbit carcass found below the inlet pipe to a 
backwash granulated activated carbon tank [30].  
4. Conclusions 
The results show the presence of Cryptosporidium spp. in the water source analyzed. Water 
sampled at the outlet of the drinking water treatment plant was usually contaminated by 
Cryptosporidium spp., even if the average oocyst concentration was lower than that in the supply 
water. The presence of the protozoa in the outlet of the DWTP can be attributed both to the lack of 
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retention of the protozoa by the filtration phase and to the resistance of the oocysts to standard 
disinfectants, such as chlorine. 
The results obtained using the molecular protocol (RT-PCR) highlighted that this method can be 
useful to evaluate the viability of the oocysts of C. parvum and C. hominis, which are the most 
important species for human health. Further analysis carried out by nested PCR on the samples of 
July 2015 revealed the presence of genotypes likely derived from wild animals (i.e., bank vole), which 
should not represent a risk for human health. In this rural and pre-mountainous area, there are no 
cattle and sheep farms, so wild animals and birds can contribute more to surface water 
contamination. Although no contamination by pathogenic Cryptosporidium species was detected in 
the water samples investigated, the results obtained show that this stream can be classified as a source 
of risk and indicate the need for continuous control of this water resource. The supply source and the 
drinking water treatment plant examined are a classic example of a system that requires continuous 
monitoring to guarantee population health. It is possible that a similar situation exists in many areas 
near the Italian Alps or Apennines. Therefore, this experience should motivate the control of water 
resources for human consumption in these areas by competent authorities. Furthermore, the 
effectiveness of the UV treatment plant must be constantly monitored and possibly modified, making 
it more effective at inactivating protozoa in order to provide additional protection for the user 
population. This finding, in turn, underlines the importance of also monitoring unconventional (non-
bacterial) biological contaminations (protozoa) in rural areas, including those of developed countries, 
thereby enhancing the importance of tailored water safety plans. 
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